StreetInsider.com News Articles

Form 4 OMNICELL, INC. For: Aug 15 Filed by: LIPPS RANDALL A

Tue, 18 Aug 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260818/26944177.html

Form 4 OMNICELL, INC. For: Aug 15 Filed by: LIPPS RANDALL A

Tue, 18 Aug 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260818/26944177.html

Form 4 OMNICELL, INC. For: Aug 15 Filed by: NUTT BRIAN H.

Tue, 18 Aug 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260818/26944179.html

Form 4 OMNICELL, INC. For: Aug 15 Filed by: NUTT BRIAN H.

Tue, 18 Aug 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260818/26944179.html

Form 4 OMNICELL, INC. For: Aug 15 Filed by: Njoku Nnamdi

Tue, 18 Aug 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260818/26944181.html

Form 4 OMNICELL, INC. For: Aug 15 Filed by: Njoku Nnamdi

Tue, 18 Aug 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260818/26944181.html

Form 4 OMNICELL, INC. For: Aug 15 Filed by: Manley Corey J

Tue, 18 Aug 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260818/26944182.html

Form 4 OMNICELL, INC. For: Aug 15 Filed by: Manley Corey J

Tue, 18 Aug 2026 16:05:00 -0400

si-local-file:///var/storage/secattach/20260818/26944182.html

Form 144 OMNICELL, INC. Filed by: Njoku Nnamdi

Mon, 17 Aug 2026 10:08:00 -0400

si-local-file:///var/storage/secattach/20260817/26936182.html

Form 144 OMNICELL, INC. Filed by: Njoku Nnamdi

Mon, 17 Aug 2026 10:08:00 -0400

si-local-file:///var/storage/secattach/20260817/26936182.html

U.S. Physical Therapy names Nchacha Etta as CFO, effective Sept. 2026

Fri, 14 Aug 2026 07:30:58 -0400

U.S. Physical Therapy, Inc. (NYSE: USPH) announced that Nchacha Etta will join the company as Executive Vice President and Chief Financial Officer, effective September 1, 2026, according to a press release from the Houston-based outpatient physical therapy operator.

Etta most recently served as Executive Vice President and CFO of Omnicell, Inc. (NASDAQ: OMCL) from 2023 to 2025. Before that, he was Senior Vice President and CFO of Essilor of America, Inc., a subsidiary of EssilorLuxottica SA, from 2019 through 2022. From 2015 to 2019, he held the role of Worldwide Vice President and CFO at Johnson & Johnson Vision. He also

U.S. Physical Therapy names Nchacha Etta as CFO, effective Sept. 2026

Fri, 14 Aug 2026 07:30:58 -0400

U.S. Physical Therapy names Nchacha Etta as CFO, effective Sept. 2026

Fri, 14 Aug 2026 07:30:58 -0400

U.S. Physical Therapy names Nchacha Etta as CFO, effective Sept. 2026

Fri, 14 Aug 2026 07:30:58 -0400

Form SCHEDULE 13G/A OMNICELL, INC. Filed by: MILLENNIUM MANAGEMENT LLC

Mon, 10 Aug 2026 18:38:00 -0400

si-local-file:///var/storage/secattach/20260810/26899539.html

Form SCHEDULE 13G/A OMNICELL, INC. Filed by: MILLENNIUM MANAGEMENT LLC

Mon, 10 Aug 2026 18:38:00 -0400

si-local-file:///var/storage/secattach/20260810/26899539.html

Form 10-Q OMNICELL, INC. For: Jun 30

Wed, 05 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260805/26874239.html

Form 10-Q OMNICELL, INC. For: Jun 30

Wed, 05 Aug 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260805/26874239.html

Omnicell (OMCL) PT Lowered to $45 at Piper Sandler

Mon, 03 Aug 2026 08:15:10 -0400

Piper Sandler analyst Jessica Tassan lowered the price target on Omnicell (NASDAQ: OMCL) to $45.00 (from $55.00) while maintaining a Overweight rating.

Omnicell (OMCL) PT Lowered to $50 at Wells Fargo

Fri, 31 Jul 2026 08:35:56 -0400

Wells Fargo analyst Stan Berenshteyn lowered the price target on Omnicell (NASDAQ: OMCL) to $50.00 (from $55.00) while maintaining a Overweight rating.

Omnicell (OMCL) PT Lowered to $65 at KeyBanc

Fri, 31 Jul 2026 05:08:17 -0400

KeyBanc analyst Scott Schoenhaus lowered the price target on Omnicell (NASDAQ: OMCL) to $65.00 (from $70.00) while maintaining a Overweight rating.

EnlivenHealth Highlights VaxReach Ahead of ThoughtSpot 2026 — Designed to Help Pharmacies Strengthen Communities Through Vaccination

Thu, 30 Jul 2026 16:01:00 -0400

New solution may help pharmacies grow monthly vaccinations by up to 66%1

FORT WORTH, Texas--(BUSINESS WIRE)-- EnlivenHealth, Inc., a subsidiary of Omnicell, Inc. (“EnlivenHealth”) and a leading innovator in pharmacy technology and patient engagement solutions, today announced the launch of VaxReach, a proactive vaccine outreach program designed to help pharmacies identify eligible patients and automatically reach them with timely messages that are intended to drive more vaccine traffic into the store. The company will highlight the program at ThoughtSpot 2026, as pharmacies prepare for respiratory and flu season, looking

EnlivenHealth Highlights VaxReach Ahead of ThoughtSpot 2026 — Designed to Help Pharmacies Strengthen Communities Through Vaccination

Thu, 30 Jul 2026 16:01:00 -0400

New solution may help pharmacies grow monthly vaccinations by up to 66%1

EnlivenHealth Highlights VaxReach Ahead of ThoughtSpot 2026 — Designed to Help Pharmacies Strengthen Communities Through Vaccination

Thu, 30 Jul 2026 16:01:00 -0400

New solution may help pharmacies grow monthly vaccinations by up to 66%1

EnlivenHealth Highlights VaxReach Ahead of ThoughtSpot 2026 — Designed to Help Pharmacies Strengthen Communities Through Vaccination

Thu, 30 Jul 2026 16:01:00 -0400

New solution may help pharmacies grow monthly vaccinations by up to 66%1